Sign in
Home
Biotech News
Conferences
Technology Conferences
Biotech Conferences
CoronaVirus
Precision Vaccinations
Internet News
Research
Reverse Splits
Reverse Split News
Reverse Split Watch List
Reverse Stock Split List
Upcoming Reverse Stock Split List
More Finance Channels
Beverage Stocks
Blockchain Stocks
Gold Stocks
Marijuana Stocks
Psychedelic Stocks
Stand Down – Wall Street Bears
Tiki Hut Fund
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Privacy Policy
Password recovery
Recover your password
your email
Search
Thursday, May 2, 2024
Sign in / Join
Contact Us
Featured News
Free Weekly Newsletter
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Internet | Biotech Stock Review
Home
Biotech News
Conferences
Technology Conferences
Biotech Conferences
CoronaVirus
Precision Vaccinations
Internet News
Research
Reverse Splits
Reverse Split News
Reverse Split Watch List
Reverse Stock Split List
Upcoming Reverse Stock Split List
More Finance Channels
Beverage Stocks
Blockchain Stocks
Gold Stocks
Marijuana Stocks
Psychedelic Stocks
Stand Down – Wall Street Bears
Tiki Hut Fund
Home
2021
May
7
Daily Archives: May 7, 2021
Stem Cells
Old News, But Wow: Starr Foundation Reaffirms Support for Stem Cell...
Editor / Curator
-
May 7, 2021
Latest article
Institutional Analyst Newsletter. Citius (CTXR), GeoVax (GOVX.
Institutional Analyst Newsletter
Editor / Curator
-
May 2, 2024
DERBY WEEKEND - WE'RE HEADED TO TAMPA!HAT'S ON, DRINK'S UPADDING CITIUS PHARMA (CTXR) $0.66, TO WATCHLISTUPDATING GEOVAX LABS (GOVX) $1.43OUR $26...
Adding Citius Pharma (CTXR) $0.66 to 2024 Watch List.
2024 Watch List
Editor / Curator
-
April 29, 2024
Three Years Since we Last Added Citius (CTXR) to the Watch List, and it Looks Better Than Ever!
Citius Pharmaceuticals (CTXR) Prospectus, Powerpoint & Fact Sheet.
2024 Watch List
Editor / Curator
-
April 27, 2024
CRANFORD, N.J., April 26, 2024 /PRNewswire/ -- Citius Pharmaceuticals Inc. (Nasdaq: CTXR) ("Citius" or the "Company"), a late-stage biopharmaceutical company dedicated to the development and commercialization...
Edit with Live CSS